Ligand profile
5MU
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_00743 — Elongation factor Tu
Identifiers
Database identifiers and provenance.
- Ligand ID
5MU- PDB
5afi- UniProt (similar protein)
P0CE48- Target protein
- KP13_00743
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 171.3
- −1 ≤ LogP ≤ 5 -2.43
- MW ≤ 500 Da 338.2
- LogP ≤ 5 -2.43
- H-bond donors ≤ 5 5
- H-bond acceptors ≤ 10 8
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 171.3
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CC1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)OCC1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O
InChI=1S/C10H15N2O9P/c1-4-2-12(10(16)11-8(4)15)9-7(14)6(13)5(21-9)3-20-22(17,18)19/h2,5-7,9,13-14H,3H2,1H3,(H,11,15,16)(H2,17,18,19)/t5-,6-,7-,9-/m1/s1InChI=1S/C10H15N2O9P/c1-4-2-12(10(16)11-8(4)15)9-7(14)6(13)5(21-9)3-20-22(17,18)19/h2,5-7,9,13-14H,3H2,1H3,(H,11,15,16)(H2,17,18,19)/t5-,6-,7-,9-/m1/s1
IGWHDMPTQKSDTL-JXOAFFINSA-NIGWHDMPTQKSDTL-JXOAFFINSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Source
- PDB
- Binding sites
- PF03143
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand 5MU →
- PDB RCSB structure 5afi →
- UniProt UniProt P0CE48 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “5MU”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_00743.
PDB 19
Ligands co-crystallized with this protein (structural evidence).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).